About Company
LumaBridge LLC is a specialized clinical research organization (CRO) focused on oncology, providing comprehensive research services to biopharmaceutical companies. The organization is dedicated to advancing novel immunotherapies and offers tailored solutions throughout the clinical development process.LumaBridge specializes in designing and executing innovative clinical trial solutions specifically for emerging biopharma companies.
The company provides a range of services including clinical data management, regulatory affairs, clinical operations, and strategic consultation on trial design. With a strong emphasis on personalized attention and flexibility, LumaBridge aims to support its clients in navigating complex clinical and regulatory pathways effectively.The organization was founded by Dr. George Peoples and Dan Hargrove, leveraging their extensive experience in academic and military research to foster advancements in immuno-oncology.
LumaBridge's mission is to act as a strategic partner, guiding clients through the entire continuum of clinical development to facilitate the timely delivery of life-changing therapies to patients.